Merck bets up to $1B on Pearl’s ‘smart’ biomaterial jewels as biotech begins to raise fresh funds
Pearl Bio was spun out of research from Farren Isaacs, Ph.D., and Michael Jewett, Ph.D., that centers on using ”genomically recoded organisms” to add synthetic chemistry to biologics.